Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Joo Kim

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The Lancet. Oncology|October 21, 2015
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialRobert J Motzer, Thomas E Hutson, Hilary Glen, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 30, 2024
Structure-Guided Engineering of Thermodynamically Enhanced SaCas9 for Improved Gene SuppressionEun Sung Kang, Nam Hyeong Kim, Hyun-Kyoung Lim, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The Lancet. Oncology|October 21, 2015
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialRobert J Motzer, Thomas E Hutson, Hilary Glen, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 30, 2024
Structure-Guided Engineering of Thermodynamically Enhanced SaCas9 for Improved Gene SuppressionEun Sung Kang, Nam Hyeong Kim, Hyun-Kyoung Lim, et al.
Pageof 4